|
|
VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7 the "Company" or "Gemina" today announces that it has licensed a novel biosensing architecture from the University of British Columbia.This licence is the culmination of a programme of research commenced between Gemina and the University of British Columbia in 2021. It lays the foundation for... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / April 2, 2024 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7 the "Company" or "Gemina" is pleased to announce the signing of a license agreement with a significant global diagnostics company. The license agreement is the culmination of Geminas commercialization program to date and will enable our new licensing partner to develop, manufacture and sell... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7 the "Company" or "Gemina" is pleased to provide a strategic update and outlook for 2024 and beyond. The Company is beginning to see results from its 2023 focus on developing large scale commercial partnerships. Our emphasis on developing multiple revenue streams, including product... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / March 19, 2024 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7 the "Company" or "Gemina" is pleased to announce that further to its news release dated February 22, 2024, it has raised gross proceeds of $910,000 under its nonbrokered private placement the "Private Placement" of unsecured convertible notes of the Company the "Notes"... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7, a diagnostics technology company, is pleased to announce that it has appointed the global investment bank Stifel as its sole and exclusive financial advisor to the Company, as it considers strategic licensing and partnership opportunities for its breakthrough diagnostics technology.Gemina is targeting a... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7 the "Company" or "Gemina" is excited to announce another major innovation in lateral flow assay "LFA" test design resulting from its innovative, patented Gemina Bridge chemistry platform. Gemina Labs has deployed cellulose paper test strips in the lateral flow assay format, a fully... Lire le communiqué |
|
| |
|
| |
|
|
Gemina to present achievement of another significant technical milestone.VANCOUVER, BC / ACCESSWIRE / June 15, 2023 / Gemina Laboratories Ltd. CSE:GLABFRA:8I7, a specialist in fast, affordable, and accurate diagnostic tests, is pleased to announce the companys attendance at the American Association of Clinical Chemistry "AACC" Annual Scientific Meeting & Clinical Lab Expo running... Lire le communiqué |
|
| |
|
| |
